© All rights reserved to Barnea Jaffa Lande & Co. Law offices

Together is global

Together is global

Technology / Life Sciences

Our team has extensive experience in advising Israeli and foreign companies in the fields of biotechnology, medical instrumentation, pharmaceuticals, diagnostic instrumentation, imaging and more

Barnea‘s activities in the healthcare sector include providing ongoing legal support from the R&D stage through to the finished product. This encompasses drafting applications for government support, protecting and building an intellectual property strategy, and advising on compliance with regulatory reporting requirements. We also prepare various agreements for clients, including cooperation agreements; clinical trial agreements with research institutes, academic institutions, and hospitals; and more.

 

In addition, we counsel clients in this sector on investment agreements, capital raising, and purchase transactions, as well as vis-à-vis investors.

 

The firm represents both Israeli and international entrepreneurs, venture capital funds, private funds, technology transfer companies in academic institutions and hospitals, and medical equipment companies. 

 

Back to Technology

News and updates - Technology / Life Sciences:


December 12, 2019

Representing Sartorius in the acquisition of a majority stake in Biological Industries.

Our firm represented Sartorius, a leading multinational corporation in the field of life science, research and development  and biopharmaceutical industry, in a transaction to acquire a majority stake in the Israeli cell culture developer Biological Industries. Sartorius acquired the majority of Biological Industries shares by way of secondary purchase of shares from the Development Company of Kibbutz Beit Haemek and private equity fund Fortissimo Capital, in consideration for USD 50 million. In addition, as part of the transaction, Sartorius and the Development Company of Kibbutz Beit Haemek signed an option to purchase/sell additional holdings in the future.

November 20, 2019

Podcast: Ariella Dreyfuss for 50inTech on Femtech

Ariella Dreyfuss talks to 50inTech in a special podcast about the growing femtech industry. She discusses challenges facing entrepreneurs in the field and offers advice on how to talk to investors.

September 15, 2019

Barnea Represented CryoLife in a Strategic Transaction with the Israeli Medtech Startup Endospan

Our firm represented CryoLife in a strategic transaction with Israel-based endovascular stent graft system developer Endospan. The transaction involved an option to purchase Endospan for up to USD 450 million in the future, together with an exclusive distribution arrangement and USD 15 million in secured debt financing.

 

 

Technology / Life Sciences

Our team has extensive experience in advising Israeli and foreign companies in the fields of biotechnology, medical instrumentation, pharmaceuticals, diagnostic instrumentation, imaging and more

Barnea‘s activities in the healthcare sector include providing ongoing legal support from the R&D stage through to the finished product. This encompasses drafting applications for government support, protecting and building an intellectual property strategy, and advising on compliance with regulatory reporting requirements. We also prepare various agreements for clients, including cooperation agreements; clinical trial agreements with research institutes, academic institutions, and hospitals; and more.

 

In addition, we counsel clients in this sector on investment agreements, capital raising, and purchase transactions, as well as vis-à-vis investors.

 

The firm represents both Israeli and international entrepreneurs, venture capital funds, private funds, technology transfer companies in academic institutions and hospitals, and medical equipment companies. 

 

Back to Technology

News and updates - Technology:


December 12, 2019

Representing Sartorius in the acquisition of a majority stake in Biological Industries.

Our firm represented Sartorius, a leading multinational corporation in the field of life science, research and development  and biopharmaceutical industry, in a transaction to acquire a majority stake in the Israeli cell culture developer Biological Industries. Sartorius acquired the majority of Biological Industries shares by way of secondary purchase of shares from the Development Company of Kibbutz Beit Haemek and private equity fund Fortissimo Capital, in consideration for USD 50 million. In addition, as part of the transaction, Sartorius and the Development Company of Kibbutz Beit Haemek signed an option to purchase/sell additional holdings in the future.

November 20, 2019

Podcast: Ariella Dreyfuss for 50inTech on Femtech

Ariella Dreyfuss talks to 50inTech in a special podcast about the growing femtech industry. She discusses challenges facing entrepreneurs in the field and offers advice on how to talk to investors.

September 15, 2019

Barnea Represented CryoLife in a Strategic Transaction with the Israeli Medtech Startup Endospan

Our firm represented CryoLife in a strategic transaction with Israel-based endovascular stent graft system developer Endospan. The transaction involved an option to purchase Endospan for up to USD 450 million in the future, together with an exclusive distribution arrangement and USD 15 million in secured debt financing.

 

 

Enter your email for newsletter sign up: